1-((4,5-bis(4-methoxyphenyl)-2-thiazoyl)carbonyl)-4-methylpiperazine has been researched along with n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide in 2 studies
Studies (1-((4,5-bis(4-methoxyphenyl)-2-thiazoyl)carbonyl)-4-methylpiperazine) | Trials (1-((4,5-bis(4-methoxyphenyl)-2-thiazoyl)carbonyl)-4-methylpiperazine) | Recent Studies (post-2010) (1-((4,5-bis(4-methoxyphenyl)-2-thiazoyl)carbonyl)-4-methylpiperazine) | Studies (n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide) | Trials (n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide) | Recent Studies (post-2010) (n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide) |
---|---|---|---|---|---|
15 | 0 | 6 | 1,220 | 3 | 229 |
Protein | Taxonomy | 1-((4,5-bis(4-methoxyphenyl)-2-thiazoyl)carbonyl)-4-methylpiperazine (IC50) | n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide (IC50) |
---|---|---|---|
Prostaglandin E synthase | Homo sapiens (human) | 10 | |
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 2.1 | |
Aromatase | Homo sapiens (human) | 0.68 | |
Prostaglandin G/H synthase 1 | Mus musculus (house mouse) | 1.67 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 3 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.9037 | |
Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 2.4333 | |
Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.1522 | |
Carboxypeptidase B2 | Homo sapiens (human) | 1.8 | |
Prostaglandin E synthase | Mus musculus (house mouse) | 0.007 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, T; Motoyama, Y; Ochi, T | 1 |
Edwards, RM; Evans, C; Hieble, JP; McCafferty, GP; Wibberley, A | 1 |
2 other study(ies) available for 1-((4,5-bis(4-methoxyphenyl)-2-thiazoyl)carbonyl)-4-methylpiperazine and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
Article | Year |
---|---|
The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models.
Topics: Acetic Acid; Analgesics; Animals; Behavior, Animal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Formaldehyde; Humans; Indomethacin; Isoenzymes; Male; Membrane Proteins; Mice; Nitrobenzenes; Pain Measurement; Piperazines; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Sprague-Dawley; Sulfonamides; Thiazoles | 2000 |
Dual, but not selective, COX-1 and COX-2 inhibitors, attenuate acetic acid-evoked bladder irritation in the anaesthetised female cat.
Topics: Acetic Acid; Anesthesia; Animals; Cats; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Indomethacin; Ketoprofen; Male; Nitrobenzenes; Piperazines; Reflex, Abnormal; Sodium Chloride; Sulfonamides; Thiazoles; Urinary Bladder Diseases | 2006 |